NCT02183090View on ClinicalTrials.gov

Pharmacokinetics and Tolerability of Meloxicam Injected Intramuscularly vs. Tablet in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 1998

Primary Completion Date

December 31, 1998

Conditions
Healthy
Interventions
DRUG

Meloxicam ampoule

DRUG

Meloxicam tablet

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY